Neovascular age-related macular degeneration Trials in Phoenix, United States
Conditions / Neovascular age-related macular degeneration / Phoenix, United States
Neovascular age-related macular degeneration is a medical condition with active clinical research programs worldwide.
33 total trials for this combination
Showing top 10 of 33 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04757636 | OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD) | TERMINATED | PHASE3 |
| NCT03683251 | Extension Study for the Port Delivery System With Ranibizumab (Portal) | RECRUITING | — |
| NCT04423718 | Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye | COMPLETED | PHASE3 |
| NCT03683251 | Extension Study for the Port Delivery System With Ranibizumab (Portal) | RECRUITING | — |
| NCT04757610 | OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD) | TERMINATED | PHASE3 |
| NCT04777201 | A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration | COMPLETED | PHASE3 |
| NCT03683251 | Extension Study for the Port Delivery System With Ranibizumab (Portal) | RECRUITING | — |
| NCT05476926 | A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products | ACTIVE_NOT_RECRUITING | — |
| NCT03683251 | Extension Study for the Port Delivery System With Ranibizumab (Portal) | RECRUITING | — |
| NCT03683251 | Extension Study for the Port Delivery System With Ranibizumab (Portal) | RECRUITING | — |